Schizophrenia Study In Adults

NCT00049946 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: talnetant
DRUG: risperidone

Sponsor

GlaxoSmithKline